The E.Coli derived recombinant B5R protein contains the Envelope Monkeypox immunodominant regions, having an Mw of 32kDa. The Monkeypox protein is fused to a 6xHis tag at C-terminus and purified by proprietary chromatographic technique
Monkeypox virus is a viral zoonotic disease transmitted to humans through contact with infected animals, primarily rodents and primates. Symptoms of monkeypox are similar to smallpox, but milder. The virus responsible for monkeypox is an enveloped double-stranded DNA virus, approximately 190 kb in size, belonging to the Orthopoxvirus genus within the Poxviridae family. There are two main genetic clades of monkeypox: the Central African clade, known for its higher transmissibility, and the West African clade. Transmission occurs through bites from infected animals or direct contact with bodily fluids. The incubation period typically lasts 12 days. Common symptoms include fever, rash, headache, swollen lymph nodes, and muscle pain.
The recombinant B5R protein, derived from E. coli, encompasses the immunodominant regions of the Monkeypox virus envelope protein and has a molecular weight of 32 kDa. It is tagged with a C-terminal 6xHis tag and purified using a proprietary chromatographic method.
A clear, sterile-filtered solution.
The recombinant Monkeypox protein solution is supplied in PBS buffer containing 0.05% sodium nitrate and 25mM potassium carbonate (K2CO3).
Upon receipt, store at -20°C. Repeated freezing and thawing should be avoided.
The purity of the protein is greater than 95% as determined by SDS-PAGE analysis using Coomassie blue staining.
Escherichia Coli.
B5R is a membrane-associated glycoprotein encoded by the monkeypox virus (MPXV), belonging to the orthopoxvirus genus. This protein is orthologous to the cowpox virus strain Brighton red (BR) B5R gene . Its significance lies in its unique genetic characteristics that distinguish MPXV from other orthopoxviruses, making it valuable for both diagnostic development and vaccine design. The protein contains specific antigenic determinants that can elicit immune responses, contributing to its importance as a vaccine target .
The B5R protein has gained research attention because:
It contains single nucleotide polymorphisms specific to monkeypox virus
It serves as an effective diagnostic marker due to its specificity
It represents a promising immunogenic target for vaccine development
It participates in host-pathogen interactions during infection
Diagnostic assays targeting B5R take advantage of single nucleotide polymorphisms within a small sequence of the monkeypox virus ortholog gene to COP-B5R. These genetic differences make such assays highly sensitive and specific to only monkeypox virus . DNA testing based on B5R requires collection of specimens while the virus is still present and cannot diagnose monkeypox after the infection has cleared.
This diagnostic approach differs from antibody-based methods that detect host immune responses, such as:
Diagnostic Approach | Target | Advantages | Limitations |
---|---|---|---|
B5R DNA testing | Viral genetic material | Highly specific to monkeypox | Requires active infection |
IgM antibody assay | Host antibody response | Can detect recent infection | Cross-reactivity concerns |
Whole-virus ELISA | Antibody titer ratios | Distinguishes between viral species | Requires sophisticated analysis |
BR-219 peptide ELISA | Antibody to unique protein | Differentiates from smallpox vaccination | Limited validation data |
Researchers should note that B5R-based diagnostics complement other approaches but require active viral presence, making timing of sample collection critical .
B5R has emerged as a promising vaccine target due to its immunogenicity and accessibility to the immune system. Research indicates that B5R contains multiple epitopes recognized by different components of the immune system, including:
Cytotoxic T-lymphocyte (CTL) epitopes
Helper T-lymphocyte (HTL) epitopes
These epitopes can be identified through immunoinformatic approaches and combined with epitopes from other immunogenic proteins (such as L1R and A33R) to create multiepitope subunit vaccines . Molecular dynamics simulation analysis confirms that properly designed B5R-based vaccine constructs maintain appropriate protein folding, which is essential for immunogenicity .
The protein's strong interaction potential with human TLR-2 (as verified through molecular docking and determination of dissociation constant values) further supports its suitability as a vaccine component .
Epitope mapping of B5R provides critical insights for rational vaccine design against monkeypox. Immunoinformatic approaches have been employed to screen for immunogenic epitopes within B5R that can stimulate multiple arms of the immune system . This methodological approach offers several advantages:
Identification of specific antigenic determinants that elicit strong immune responses
Selection of epitopes that can stimulate both cellular and humoral immunity
Exclusion of potentially allergenic or reactogenic protein segments
Design of multiepitope constructs with optimized immunogenicity
The research methodology typically follows this workflow:
Computational prediction of potential epitopes using multiple algorithms
Filtering based on conservation, accessibility, and immunogenicity scores
Joining selected epitopes with appropriate linkers to maintain independent functionality
3D structure prediction and molecular dynamics simulation to confirm proper folding
Verification of binding to immune receptors (such as TLR-2) through molecular docking
Assessment of expression potential through GC content and codon adaptation index analysis
Immune response simulation to predict antibody production profiles
This approach has demonstrated that vaccines constructed with carefully selected B5R epitopes can robustly activate the immune system, triggering high titers of IgG and IgM antibodies when tested in simulation models .
The analysis of B5R genetic variations requires sophisticated methodologies that can detect subtle genetic differences with high specificity. Current research suggests the following approaches are most effective:
High-resolution DNA sequencing: Targeted sequencing of the B5R gene region allows identification of single nucleotide polymorphisms (SNPs) that differentiate between monkeypox strains and from other orthopoxviruses .
Phylogenetic analysis: Comparing B5R sequences across different monkeypox isolates enables the construction of evolutionary relationships and identification of strain-specific markers.
Molecular typing assays: Development of PCR-based methods that specifically target the unique SNPs within B5R provides a rapid way to differentiate between monkeypox strains.
Bioinformatic comparative analyses: These can reveal patterns of conservation and variation that may correlate with virulence or host adaptation.
The diagnostic specificity of B5R-based assays demonstrates the utility of focusing on this gene's distinctive characteristics when developing molecular tools for monkeypox detection and classification .
B5R-targeted vaccines represent a modern, targeted approach that differs significantly from historical orthopoxvirus vaccines. The comparison highlights important methodological advancements:
Vaccine Type | Example | Mechanism | Advantages | Limitations |
---|---|---|---|---|
Historical live virus | Dryvax | Whole attenuated virus | Broad protection | Reactogenicity, contraindications |
Second generation | ACAM2000 | Cloned virus strain | Consistent production | Safety concerns remain |
Third generation | Modified Vaccinia Ankara (MVA) | Highly attenuated strain | Improved safety profile | May require multiple doses |
B5R-targeted subunit | Multiepitope constructs | Selected antigenic determinants | Precise immune targeting, minimal side effects | Narrower protection profile |
Research indicates that B5R-targeted approaches offer several advantages:
Molecular dynamics simulation confirms proper folding of designed vaccines containing B5R epitopes
Strong binding to human TLR-2 verified through molecular docking indicates effective immune activation
High expression potential in bacterial systems as confirmed by GC content and codon adaptation index values
Immune response simulation data shows robust activation with production of high titers of IgG and IgM antibodies
The selection of appropriate experimental models for studying B5R functionality is critical for meaningful research outcomes. Based on the literature, several models have proven valuable for orthopoxvirus research and may be suitable for B5R-specific studies:
Cynomolgus macaque model: This non-human primate model has been successfully used to investigate vaccine efficacy against monkeypox. Studies have shown that vaccines elicit heterologous T-cell and antibody responses in this model, with protection against respiratory infection with monkeypox .
Rhesus monkey model: Researchers have demonstrated that DNA vaccines containing orthopoxvirus genes (including those homologous to B5R) can protect rhesus monkeys from monkeypox challenge, producing neutralizing antibodies that cross-react with monkeypox proteins .
Mouse models: While less directly translatable to human disease, mouse models permit larger sample sizes and genetic manipulation. They have been used to investigate the efficacy of gene-based vaccines against poxviruses .
Cell-based systems: In vitro models using relevant cell lines can provide insights into the cellular interactions of B5R and are useful for initial screening of therapeutic candidates.
When selecting an experimental model, researchers should consider:
The specific research question (pathogenesis, vaccine development, therapeutic testing)
Required physiological similarity to human disease
Ethical considerations and regulatory requirements
Available facilities and expertise
Budget constraints and timelines
The cynomolgus macaque model appears particularly valuable, as demonstrated in studies where vaccine efficacy could be rigorously assessed against monkeypox challenge .
Immunoinformatic techniques have revolutionized our approach to understanding viral proteins like B5R and their interactions with the host immune system. These computational methods offer powerful tools for researchers:
Epitope prediction algorithms: These can identify potential B-cell and T-cell epitopes within B5R with high accuracy, guiding experimental validation efforts.
Structural modeling and simulation: As demonstrated in recent research, 3D structure prediction followed by molecular dynamics simulation can confirm proper protein folding, which is essential for understanding function and designing interventions .
Molecular docking studies: These have verified strong binding of B5R-derived constructs with human TLR-2, providing insights into immune activation mechanisms .
Expression prediction tools: Assessment of GC content and codon adaptation index (CAI) values can predict expression efficiency in production systems, an important consideration for vaccine development .
Immune response simulation: Computational models can predict how the immune system will respond to B5R-derived vaccines, including antibody production kinetics .
The integration of these techniques has already yielded promising results in monkeypox research, providing "a solid base of concept to develop dynamic and effective vaccines that contain several monkeypox virus-derived highly antigenic and nonallergenic peptides" .
Despite advances in understanding B5R, several critical knowledge gaps remain that warrant further investigation:
Structure-function relationships: Detailed structural studies of B5R are needed to better understand its role in viral pathogenesis and host interaction.
Epitope conservation: Further research is required to determine the conservation of B5R epitopes across different monkeypox strains, particularly between Central and West African clades.
Correlates of protection: The specific immune responses to B5R that correlate with protection against monkeypox infection need to be better defined.
Host range determinants: The role of B5R in determining host range and species-specific pathogenicity remains incompletely understood.
Evolutionary dynamics: How B5R has evolved within orthopoxviruses and its relationship to virulence and transmissibility requires further study.
Addressing these gaps will require integrative approaches combining genomics, proteomics, structural biology, and immunology.
Research on B5R has significant implications for public health preparedness against both monkeypox and potential future orthopoxvirus threats:
Broad-spectrum diagnostics: Understanding the genetic diversity of B5R across orthopoxviruses could lead to development of diagnostic platforms capable of detecting and differentiating multiple species.
Adaptable vaccine platforms: The immunoinformatic approaches used for B5R-targeted vaccine design provide a framework that could be rapidly adapted to address emerging orthopoxvirus threats .
Cross-protective immunity: Research exploring cross-reactive epitopes within B5R may identify targets for broadly protective vaccines.
Surveillance tools: Knowledge of B5R variation could inform molecular surveillance systems for early detection of orthopoxvirus outbreaks and tracking of viral evolution.
Risk assessment models: Understanding the functional implications of B5R mutations could contribute to better prediction of virulence and transmissibility of novel orthopoxvirus strains.
In the context of diminishing population immunity to orthopoxviruses following the cessation of routine smallpox vaccination, research on specific targets like B5R becomes increasingly important for maintaining preparedness capabilities .
Monkeypox is a zoonotic disease caused by the monkeypox virus, which belongs to the Orthopoxvirus genus of the Poxviridae family. The virus was first discovered in 1958 when outbreaks occurred in monkeys kept for research. The first human case was recorded in 1970 in the Democratic Republic of the Congo (DRC), and since then, the infection has been reported in several African countries .
The monkeypox virus has a complex structure and contains several genes that play crucial roles in its replication and pathogenicity. Among these genes, the B5R gene is of particular interest due to its involvement in the virus’s ability to evade the host immune response and facilitate viral spread.
The B5R gene encodes a protein that is essential for the formation of extracellular enveloped virus (EEV), a form of the virus that is released from infected cells and can spread to other cells. The B5R protein is involved in the wrapping of the virus with an additional membrane, which helps the virus evade the host immune system and enhances its ability to infect other cells .
Recombinant B5R protein refers to the B5R protein that has been produced using recombinant DNA technology. This involves inserting the B5R gene into a suitable expression system, such as bacteria or mammalian cells, to produce the protein in large quantities. Recombinant B5R protein is used in various research applications, including the development of vaccines and diagnostic tests.
The B5R protein is a target for vaccine development due to its role in the formation of EEV and its ability to elicit an immune response. Vaccines that include the B5R protein can potentially provide protection against monkeypox by inducing the production of antibodies that neutralize the virus and prevent its spread. Recent studies have shown promising results with recombinant vaccines that use genetically modified vaccinia virus to express monkeypox antigens, including the B5R protein .